Patients with ischemic heart disease, a serious condition that occurs when the heart’s arteries become clogged with cholesterol plaque, may have new options if they have exhausted traditional cardiovascular therapies. A newclinical trial is using patients’ own stem cells to improve circulation in hearts damaged by inadequate blood flow, by promoting the growth of new, microscopic blood vessels.